In HCV infected patients with cirrhosis Squamous Cell Carcinoma Antigen (SCCA)-IgM levels may contribute to identify the individual risk of HCC development after antiviral therapy. Issue 1 (16th February 2017) - Ricco, G.; Cavallone, D.; Pontisso, P.; Fassina, G.; Gallotta, A.; Colombatto, P.; Oliveri, F.; Romagnoli, V.; Coco, B.; Salvati, A.; Bonino, F.; Brunetto, M.R.